Compare AVNT & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNT | MMED |
|---|---|---|
| Founded | 1927 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.1B |
| IPO Year | 2000 | 2026 |
| Metric | AVNT | MMED |
|---|---|---|
| Price | $33.71 | $10.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $41.50 | $22.56 |
| AVG Volume (30 Days) | 533.0K | ★ 619.2K |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $3,835,500,000.00 | N/A |
| Revenue This Year | $4.90 | $15.99 |
| Revenue Next Year | $3.48 | $10.00 |
| P/E Ratio | $56.89 | ★ N/A |
| Revenue Growth | ★ 1.71 | N/A |
| 52 Week Low | $27.48 | $10.92 |
| 52 Week High | $44.85 | $17.86 |
| Indicator | AVNT | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 32.01 |
| Support Level | $30.58 | N/A |
| Resistance Level | $38.62 | $15.80 |
| Average True Range (ATR) | 1.35 | 0.71 |
| MACD | -0.36 | -0.04 |
| Stochastic Oscillator | 2.36 | 8.78 |
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.